Breaking News Instant updates and real-time market news.

MDC

M.D.C. Holdings

$32.04

-0.045 (-0.14%)

, TOL

Toll Brothers

$37.08

-0.05 (-0.13%)

12:30
08/29/18
08/29
12:30
08/29/18
12:30

Homebuilder stocks may signal trouble as group lags broader market, WSJ says

Despite consumer confidence tracking close to 18-year highs, "strong corporate earnings and soaring retail sales," shares of home builders are struggling, "pointing to a potential trouble spot in an otherwise resilient U.S. economy," says the Wall Street Journal. "With the FOMC having elevated housing to a key downside risk to the U.S. economy... should continue to raise caution around the housing market, though current levels are still suggesting resilient growth," said Jon Hill, rates strategist at BMO Capital Markets, according to the WSJ report. Publicly traded companies in the space include Beazer Homes (BZH), CalAtlantic (CAA), D.R. Horton (DHI), Hovnanian (HOV), KB Home (KBH), Lennar (LEN), M.D.C. Holdings (MDC), PulteGroup (PHM) and Toll Brothers (TOL). Reference Link

MDC

M.D.C. Holdings

$32.04

-0.045 (-0.14%)

TOL

Toll Brothers

$37.08

-0.05 (-0.13%)

HOV

Hovnanian

$1.54

0.015 (0.98%)

DHI

D.R. Horton

$45.41

0.1 (0.22%)

KBH

KB Home

$25.35

-0.03 (-0.12%)

PHM

PulteGroup

$28.42

-0.015 (-0.05%)

BZH

Beazer Homes

$12.91

-0.07 (-0.54%)

LEN

Lennar

$52.88

0.27 (0.51%)

CAA

CalAtlantic

$0.00

(0.00%)

  • 30

    Aug

  • 06

    Sep

  • 10

    Sep

MDC M.D.C. Holdings
$32.04

-0.045 (-0.14%)

08/02/18
BOFA
08/02/18
UPGRADE
BOFA
Buy
M.D.C. Holdings upgraded to Buy from Underperform at BofA/Merrill
07/13/18
JPMS
07/13/18
UPGRADE
Target $36
JPMS
Neutral
M.D.C. Holdings upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Michael Rehaut upgraded M.D.C. Holdings to Neutral while lowering his price target for the shares to $36 from $38. The anlayst says the current valuation appropriately reflects his outlook for above average order growth and margin expansion in 2018.
08/02/18
08/02/18
UPGRADE
Target $42

Buy
M.D.C. Holdings double upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill double upgraded M.D.C Holdings to Buy from Underperform and increased its price target to $42 from $36. Analyst John Lovallo is encouraged by M.D.C.'s "solid" Q2 performance, especially gross margin expansion, and expect execution to continue. The analyst said the company's increased focus on the entry-level home-buyer as a positive given the large Millennial demographic and recent returns of this segment.
07/13/18
07/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. VF Corp. (VFC) upgraded two notches to Buy from Underperform at BofA/Merrill with analyst Robert Ohmes saying he believes Vans momentum is sustainable and will be a "go-to-brand" for the back-to-school selling season. 2. United Rentals (URI) and Herc Holdings (HRI) were upgraded to Buy from Neutral at Buckingham. 3. Raymond James (RJF) upgraded to Buy from Neutral at Citi with analyst William Katz saying he still prefers alternative managers. 4. M.D.C. Holdings (MDC) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the current valuation appropriately reflects his outlook for above average order growth and margin expansion in 2018. 5. BlackRock (BLK) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying shares deserve a premium valuation given its strong secular position and views the recent sell-off as a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TOL Toll Brothers
$37.08

-0.05 (-0.13%)

08/07/18
MZHO
08/07/18
DOWNGRADE
Target $31
MZHO
Neutral
PulteGroup downgraded to Neutral from Buy at Mizuho
Mizuho analyst Haendel St. Juste downgraded PulteGroup (PHM) to Neutral and lowered his price target for the shares to $31 from $36. The analyst sees an "imbalanced risk/reward" profile for the shares with a lack of near-term catalysts. PulteGroup's valuation is "richer" and its 2019 earnings slower relative to peers, St. Juste tells investors in a research note. The analyst remains constructive on housing/homebuilders and favors shares of Lennar (LEN) and Toll Brothers (TOL).
06/27/18
RBCM
06/27/18
INITIATION
RBCM
Outperform
Toll Brothers assumed with an Outperform at RBC Capital
06/27/18
RBCM
06/27/18
INITIATION
Target $46
RBCM
Outperform
Toll Brothers assumed with an Outperform at RBC Capital
RBC Capital analyst Michael Dahl assumed Toll Brothers with an Outperform rating and a price target of $46, saying the pullback in the stock price after Q2 earnings, as well as the 27% year-to-date decline, is a buying opportunity. Dahl notes that the modest risk around gross margin expectations is priced in, anticipating sufficient revenue growth to keep operating margins stable and above-average levels. The analyst believes that underlying demand remains healthy and the slowing order growth in Q2 was due to declining community count rather than the impact of rising rates.
06/19/18
SBSH
06/19/18
INITIATION
Target $42
SBSH
Neutral
Toll Brothers assumed with a Neutral at Citi
Citi analyst Scott Schrier assumed coverage of Toll Brothers with a Neutral rating and $42 price target. The analyst took over coverage of the Building Products, Construction Materials group.
HOV Hovnanian
$1.54

0.015 (0.98%)

12/22/17
12/22/17
DOWNGRADE
Target $1.75

Sell
Hovnanian downgraded to Sell after post-earnings jump at MKM Partners
As previously reported, MKM Partners analyst Megan McGrath downgraded Hovnanian to Sell from Neutral, stating that the large positive move up on the heels of its earnings report followed what she viewed as "only a mildly positive quarter." Revenues are likely to continue to decline well into 2018 and cost headwinds are rising, not abating, McGrath tells investors. She has a $1.75 price target on the stock, which closed yesterday at $2.99.
12/22/17
12/22/17
DOWNGRADE

On The Fly: Top analyst downgrades
Catch up on today's top analyst downgrades with this list compiled by The Fly: 1. Dynagas LNG (DLNG) downgraded to Hold from Buy at Stifel with analyst Benjamin Nolan saying although the new three-year contract extension with Statoil (STO) improves cash flow visibility, the rates were below expectations and the cash flow gap has widened. 2. Hovnanian (HOV) downgraded to Sell from Neutral at MKM Partners wiht analyst Megan McGrath saying the large positive move up on the heels of its earnings report followed what she viewed as "only a mildly positive quarter." 3. Bojangles (BOJA) was downgraded to Hold from Buy at Jefferies while Wingstop (WING) and Shake Shack (SHAK) were downgraded to Underperform from Hold. 4. WWE (WWE) and Live Nation (LYV) were downgraded to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/29/17
WEDB
12/29/17
NO CHANGE
WEDB
Wedbush raises homebuilder price targets due to new tax bill
Wedbush analyst Jay McCanless increased his price targets on homebuilders by an average of 13.6% to reflect the potential impacts from the new tax bill, though he noted that his estimates and targets could need to be adjusted as companies begin reporting earnings giving specific tax guidance. He made the largest target increases to PulteGroup (PHM), Century Communities (CCS) and Taylor Morrison (TMHC), he noted. Other publicly traded companies in the space include Beazer Homes (BZH), CalAtlantic (CAA), D.R. Horton (DHI), Hovnanian (HOV), KB Home (KBH), Lennar (LEN), M.D.C. Holdings (MDC) and Toll Brothers (TOL).
12/22/17
MKMP
12/22/17
DOWNGRADE
MKMP
Sell
Hovnanian downgraded to Sell from Neutral at MKM Partners
DHI D.R. Horton
$45.41

0.1 (0.22%)

06/27/18
RBCM
06/27/18
INITIATION
Target $45
RBCM
Sector Perform
D.R. Horton assumed with a Sector Perform at RBC Capital
RBC Capital analyst Michael Dahl assumed D.R. Horton with a Sector Perform rating and a price target of $45. The analyst notes that the company is "strongly positioned to capitalize on the lack of affordable existing home inventory and capture entry-level demand, while also generating strong free cash flows" but also sees those factors reflected in its valuation, as it trades at a premium to peer group average on total book value and PE multiple basis.
08/03/18
MKMP
08/03/18
NO CHANGE
Target $52
MKMP
Neutral
D.R. Horton price target lowered to $52 from $57 at MKM Partners
MKM Partners analyst Megan McGrath lowered her price target on D.R. Horton to $52 and kept her Neutral rating after its Q3 results. The analyst notes that the company had a "strong" quarter on earnings and gross margins while other builders struggled to maintain margin pace. McGrath also raised her D.R. Horton FY18 EPS view to $3.81 from $3.58, but also warned that the housing cycle is reaching maturity based on the recent fears around interest rates and waning demand.
08/01/18
RAJA
08/01/18
UPGRADE
RAJA
Strong Buy
D.R. Horton upgraded to Strong Buy from Outperform at Raymond James
07/27/18
EVER
07/27/18
UPGRADE
EVER
Outperform
D.R. Horton upgraded to Outperform from In Line at Evercore ISI
KBH KB Home
$25.35

-0.03 (-0.12%)

07/10/18
07/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CarMax (KMX) upgraded two notches to Overweight from Underweight at Morgan Stanley with analyst Armintas Sinkevicius saying longer term, he is constructive on dealers, citing a belief that tech disruption could accelerate consolidation and set up a transition toward "megafleet managers." 2. Cummins (CMI) upgraded to Buy from Hold at Stifel with analyst Michael Baudendistel saying shares of truck equipment companies have been under pressure primarily on concerns that the cycle is at a peak. 3. Wynn Resorts (WYNN) upgraded to Buy from Hold at Stifel with analyst Steven Wieczynski saying he believes the pullback in the stock recently has created a compelling opportunity. 4. KB Home (KBH) upgraded to Positive from Neutral at Susquehanna with analyst Jack Micenko citing a "clear and visible path" to further gross margin expansion and re-acceleration in community count and order growth well into 2019 for the upgrade, adding that underlying housing trends are strong in many of the markets in which the company currently operates despite "cautious" macro sentiment. 5. Quest Diagnostics (DGX) upgraded to Outperform from In Line at Evercore ISI with analyst Ross Muken saying the company will likely be the beneficiary of improved volumes, stable pricing, heightened M&A, and fund flows amid the heightened volatility within the Rx supply chain. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/18
SUSQ
07/10/18
UPGRADE
Target $36
SUSQ
Positive
KB Home upgraded to Positive from Neutral at Susquehanna
As previously reported, Susquehanna analyst Jack Micenko upgraded KB Home to Positive from Neutral and raised his price target to $36 from $34. In a research note to investors, Micenko cited a "clear and visible path" to further gross margin expansion and re-acceleration in community count and order growth well into 2019 for the upgrade, adding that underlying housing trends are strong in many of the markets in which the company currently operates despite "cautious" macro sentiment.
07/10/18
SUSQ
07/10/18
UPGRADE
SUSQ
Positive
KB Home upgraded to Positive from Neutral at Susquehanna
06/29/18
LEHM
06/29/18
UPGRADE
LEHM
Equal Weight
KB Home upgraded to Equal Weight from Underweight at Barclays
PHM PulteGroup
$28.42

-0.015 (-0.05%)

06/19/18
SBSH
06/19/18
UPGRADE
Target $30
SBSH
Neutral
PulteGroup upgraded to Neutral from Sell at Citi
Citi analyst Scott Schrier upgraded PulteGroup to Neutral and raised his price target for the shares to $30 from $27 after assuming coverage of the Building Products, Construction Materials group.
07/27/18
BTIG
07/27/18
DOWNGRADE
Target $24
BTIG
Sell
PulteGroup downgraded to Sell from Neutral at BTIG
BTIG analyst Carl Reichhardt downgraded PulteGroup to Sell from Neutral with a price target of $24, noting that growth will underperform for the next year after order decline of about 1% in Q2. The analyst cites the company's product mix, as its exposure in the entry-level homes where demand is the strongest remains low. Reichhardt expects orders to decline about 1% in the coming 4 quarters, reducing FY19 EPS by about 3% and weighing on PulteGroup's return on equity.
06/27/18
RBCM
06/27/18
INITIATION
Target $31
RBCM
Sector Perform
PulteGroup assumed with a Sector Perform at RBC Capital
RBC Capital analyst Michael Dahl assumed PulteGroup with a Sector Perform rating and a price target of $31. The analyst expects the company to generate the best ROTE in his coverage universe in 2018 at 22.4% vs. a 15.9% peer group average, but also believes this will be a peak year as the recent significant share buybacks "ratchet down", keeping a lid on the stock price. He also expects order growth to slow to 9% this year and 5% next year from 11.5% in 2017.
BZH Beazer Homes
$12.91

-0.07 (-0.54%)

02/13/18
02/13/18
UPGRADE
Target $22

Outperform
Beazer Homes upgraded to Outperform at Wedbush
As previously reported, Wedbush analyst Jay McCanless upgraded Beazer Homes to Outperform from Neutral with a $22 price target. Noting the stock price has declined about 17% year to date, the analyst argues that the magnitude of this decline is overdone since demand is rising for Beazer Homes' core entry-level product, and the company has essentially achieved its longer-term growth targets.
02/12/18
JMPS
02/12/18
UPGRADE
JMPS
Market Perform
Beazer Homes upgraded to Market Perform from Underperform at JMP Securities
02/13/18
WEDB
02/13/18
UPGRADE
WEDB
Outperform
Beazer Homes upgraded to Outperform from Neutral at Wedbush
02/12/18
02/12/18
UPGRADE

Market Perform
Beazer Homes upgraded to Market Perform at JMP Securities
As previously reported, JMP Securities analyst Peter Martin upgraded Beazer Homes to Market Perform from Underperform, as he sees limited upside due to leverage and the company's land, labor, and material cost headwinds. Martin maintained his FY18 and FY19 estimates for Beazer, saying he believes the Orlando Gathering project will experience lower than average absorptions following two recent visits to the community.
LEN Lennar
$52.88

0.27 (0.51%)

06/27/18
MKMP
06/27/18
NO CHANGE
Target $71
MKMP
Buy
Lennar Q2 beat on all operating metrics, says MKM Partners
MKM Partners analyst Megan McGrath keeps her Buy rating and $71 price target on Lennar after its "impressive" Q2 results marked the first reported quarter following the acquisition of CalAtlantic. The analyst notes that the company beat on all the operating metrics - orders, closings, and margins - while continuing to see solid demand despite higher mortgage rates. McGrath anticipates continued near- and longer-term positives from Lennar's acquisition of CalAtlantic, benefiting through its larger local scale.
06/27/18
LEHM
06/27/18
NO CHANGE
Target $65
LEHM
Overweight
Lennar price target cut to $65 from $72 at Barclays
Barclays analyst Matthew Bouley maintained an Overweight rating on Lennar but cut his price target to $65 from $72, telling investors in a research note that the company's Q2 results serve as a favorable checkup on underlying demand trends, synergy progress and cash flow potential, with each of these demonstrating upside to prior estimates. Bouley says he views Lennar as well- positioned for continued non-cycle dependent upward earnings revisions -- synergies, boosting CAA absorptions and potential buybacks.
06/27/18
RBCM
06/27/18
INITIATION
Target $66
RBCM
Outperform
Lennar assumed with an Outperform at RBC Capital
RBC Capital analyst Michael Dahl assumed Lennar with an Outperform rating and a price target of $66, saying the company is positioned to drive above-market growth and margin improvement as a result of its integration with CalAtlantic. Dahl notes that the stock price has pulled back sharply on one-time integration costs and concerns around the impact of rising rates on the housing sector, but believes this presents a buying opportunity ahead of the "robust" FY19 earnings ramp.
CAA CalAtlantic
$0.00

(0.00%)

06/19/18
SBSH
06/19/18
INITIATION
SBSH
Buy
Lennar assumed with a Buy at Citi
Citi analyst Scott Schrier assumed coverage of Lennar with a Buy rating saying the stock's recent underperformance is overdone. The stock screens well from a valuation perspective, and the company's acquisition of CalAtlantic brings "significant synergy potential," Schrier tells investors in a research note.
05/23/18
MKMP
05/23/18
NO CHANGE
Target $71
MKMP
Buy
Lennar price target lowered to $71 from $83 at MKM Partners
MKM Partners analyst Megan McGrath lowered her price target on Lennar (LEN) to $71 to reflect the risks for home builders associated with a rising interest rate environment. McGrath keeps her Buy rating however, stating that shares can still rise "meaningfully" this year if the company can execute with the integration of its recently acquired CalAtlantic (CAA) through improved synergies. The analyst also lowers her Q2 EPS view to 44c from $1.16 to reflect the CalAtlantic investment.
02/13/18
JPMS
02/13/18
UPGRADE
Target $77
JPMS
Overweight
Lennar reinstated with an Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Rehaut upgraded Lennar (LEN) to Overweight with a $77 price target following a period of restriction. The analyst previously had a Neutral rating on the shares with a $57 price target. Lennar is attractively priced ahead of becoming a "significantly stronger company" as it integrates CalAtlantic (CAA) over the next 12-18 months, Rehaut tells investors in a research note. Lennar will likely have an "uncommonly strong market share" across most of the country following the deal, the analyst contends.
02/07/18
LEHM
02/07/18
UPGRADE
Target $72
LEHM
Overweight
Lennar upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Michael Dahl upgraded Lennar (LEN) to Overweight and raised his price target for the shares to $72 from $68 after incorporating the acquisition of CalAtlantic (CAA). The analyst now expects higher returns, margins and growth, and thinks "strong" free cash flow" creates balance sheet optionality.

TODAY'S FREE FLY STORIES

IQ

iQIYI

$18.02

0.02 (0.11%)

07:44
12/12/18
12/12
07:44
12/12/18
07:44
Initiation
iQIYI initiated  »

iQIYI initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THS

TreeHouse

$51.64

2.69 (5.50%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Recommendations
TreeHouse analyst commentary  »

TreeHouse price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$2.78

0.07 (2.58%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Hot Stocks
KemPharm presents research on IV abuse potential of SDX at ACNP »

KemPharm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCCO

Southern Copper

$32.17

-0.08 (-0.25%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Downgrade
Southern Copper rating change  »

Southern Copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THS

TreeHouse

$51.64

2.69 (5.50%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Recommendations
TreeHouse analyst commentary  »

TreeHouse price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASR

Asur

$141.69

-0.66 (-0.46%)

07:42
12/12/18
12/12
07:42
12/12/18
07:42
Upgrade
Asur rating change  »

Asur upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$142.07

0.2 (0.14%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

07:42
12/12/18
12/12
07:42
12/12/18
07:42
Recommendations
Facebook, Alphabet Class A analyst commentary  »

Facebook testing search…

FB

Facebook

$142.07

0.2 (0.14%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTM

Constellium

$8.12

0.2 (2.53%)

07:40
12/12/18
12/12
07:40
12/12/18
07:40
Conference/Events
Constellium to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 18

    Dec

ZLAB

Zai Lab

$19.93

-0.01 (-0.05%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Hot Stocks
Zai Lab announces acceptance of Zejula NDA submission by NMPA »

Zai Lab announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$114.69

1.8 (1.59%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$46.73

-0.85 (-1.79%)

07:38
12/12/18
12/12
07:38
12/12/18
07:38
Recommendations
Shake Shack analyst commentary  »

Shake Shack price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AEO

American Eagle

$19.03

-0.49 (-2.51%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Recommendations
American Eagle analyst commentary  »

American Eagle shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$110.04

-0.78 (-0.70%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Downgrade
Marriott rating change  »

Marriott downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.26

-0.04 (-3.08%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Hot Stocks
MYnd Analytics appoints Patrick Herguth CEO, George Carpenter CIO »

MYnd Analytics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.58

-0.17 (-0.69%)

, T

AT&T

$29.70

-0.21 (-0.70%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$24.58

-0.17 (-0.69%)

T

AT&T

$29.70

-0.21 (-0.70%)

NIO

NIO Inc.

$7.05

0.03 (0.43%)

BX

Blackstone

$30.50

0.03 (0.10%)

KHC

Kraft Heinz

$48.38

0.1 (0.21%)

NBR

Nabors Industries

$2.82

0.12 (4.44%)

KKR

KKR

$20.92

-0.21 (-0.99%)

TROX

Tronox

$7.11

0.06 (0.85%)

MLCO

Melco Resorts & Entertainment

$17.36

0.35 (2.06%)

DLPH

Delphi Technologies

$16.07

0.26 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

  • 30

    Jan

  • 12

    Feb

  • 20

    Mar

07:35
12/12/18
12/12
07:35
12/12/18
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

AUDVF

Audi AG

$0.00

(0.00%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Audi names interim CEO Bram Schot as chairman of the board »

The Supervisory Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTB

Cooper Tire

$30.71

0.12 (0.39%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Cooper Tire, Sailun announce JV for new TBR tire plant in Vietnam »

Cooper Tire & Rubber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDS

Aridis Pharmaceuticals

$7.96

0.02 (0.25%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Aridis Pharmaceuticals enrolls first subject in Phase 1/2a lung infection trial »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Neurocrine says valbenazine did not meet primary endpoint in Phase IIb study »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$66.30

0.58 (0.88%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$33.95

1.285 (3.93%)

07:31
12/12/18
12/12
07:31
12/12/18
07:31
Conference/Events
Health Insurance Innovations to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AQUA

Evoqua Water

$10.23

0.06 (0.59%)

07:31
12/12/18
12/12
07:31
12/12/18
07:31
Initiation
Evoqua Water initiated  »

Evoqua Water initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNTR

Pointer Telocation

$11.55

-0.25 (-2.12%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Hot Stocks
Pointer Telocation and Pricol to form joint venture for telematics solution »

Pointer Telocation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRT

Federal Realty

$133.31

0.43 (0.32%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Downgrade
Federal Realty rating change  »

Federal Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.